RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 123 filers reported holding RELMADA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.77 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $159,513 | -41.8% | 53,171 | -52.3% | 0.00% | – |
Q2 2023 | $274,049 | +11.0% | 111,402 | +2.0% | 0.00% | – |
Q1 2023 | $246,824 | -78.0% | 109,214 | -66.1% | 0.00% | – |
Q4 2022 | $1,124,112 | -96.5% | 322,095 | -63.3% | 0.00% | -100.0% |
Q3 2022 | $32,519,000 | +344.6% | 878,418 | +128.0% | 0.01% | +300.0% |
Q2 2022 | $7,315,000 | +75.4% | 385,200 | +149.3% | 0.00% | +100.0% |
Q1 2022 | $4,170,000 | -9.7% | 154,500 | -24.6% | 0.00% | – |
Q4 2021 | $4,618,000 | +84.6% | 204,910 | +114.7% | 0.00% | – |
Q3 2021 | $2,501,000 | -62.0% | 95,430 | -53.5% | 0.00% | – |
Q2 2021 | $6,574,000 | +17.7% | 205,361 | +29.4% | 0.00% | – |
Q1 2021 | $5,587,000 | +57.6% | 158,678 | +43.6% | 0.00% | – |
Q4 2020 | $3,544,000 | +43.6% | 110,512 | +68.5% | 0.00% | – |
Q3 2020 | $2,468,000 | -34.2% | 65,600 | -21.7% | 0.00% | -100.0% |
Q2 2020 | $3,750,000 | +1.3% | 83,800 | -22.8% | 0.00% | 0.0% |
Q1 2020 | $3,703,000 | +109.2% | 108,566 | +139.1% | 0.00% | – |
Q4 2019 | $1,770,000 | – | 45,399 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
VR Adviser, LLC | 2,270,072 | $61,269,000 | 9.93% |
GREAT POINT PARTNERS LLC | 790,000 | $21,322,000 | 5.15% |
ACUTA CAPITAL PARTNERS, LLC | 342,000 | $9,231,000 | 4.31% |
COWEN AND COMPANY, LLC | 1,164,361 | $31,426,000 | 3.02% |
Altium Capital Management LP | 206,000 | $5,560,000 | 1.86% |
BVF INC/IL | 1,647,400 | $44,463,000 | 1.78% |
RTW INVESTMENTS, LP | 2,540,074 | $68,557,000 | 1.42% |
Vivo Capital, LLC | 705,882 | $19,052,000 | 1.31% |
RA Capital Management | 2,000,000 | $53,980,000 | 1.18% |
SPHERA FUNDS MANAGEMENT LTD. | 291,252 | $7,861,000 | 1.11% |